ISCO
International Stem Cell CORPCompany Information
- Company Name
- International Stem Cell CORP
- CIK
- CIK0001355790
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- ISCO: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- ISCO
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2026-09-11
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 32,802
Institutional Sentiment
- As of
- 2023-03-31
- Institutional shares owned
- 20
- Shares outstanding
- 8,004,389
- Ownership
- 0.00%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- 35.48%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | ||||||
| Accounts Receivable Net Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Inventory Net | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 4 | 4 | 3 | 4 | 4 | 4 | 4 | 3 | 4 | 4 | 4 | 4 | ||||||
| Inventory Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Intangible Assets Net Excluding Goodwill | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | ||||||
| Assets | 5 | 5 | 5 | 5 | 6 | 6 | 5 | 5 | 6 | 5 | 5 | 6 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accrued Liabilities Current | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Notes Payable Current | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | ||||||
| Liabilities Current | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Liabilities | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 107 | 107 | 107 | 107 | 107 | 107 | 107 | 107 | 107 | 106 | 106 | 106 | ||||||
| Retained Earnings Accumulated Deficit | -111 | -111 | -111 | -111 | -111 | -111 | -111 | -111 | -111 | -111 | -110 | -110 | ||||||
| Stockholders Equity | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | ||||||
| Liabilities And Stockholders Equity | 5 | 5 | 5 | 5 | 6 | 6 | 5 | 5 | 6 | 5 | 5 | 6 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | 120 | ||||||
| Common Stock Shares Issued | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | ||||||
| Shares Outstanding | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialInternational Stem Cell CORP (ISCO) — SEC Financial Statements & Analysis
International Stem Cell CORP (ISCO) is a pharmaceutical preparations company, incorporated in DE. International Stem Cell CORP trades on OTC as: ISCO. International Stem Cell CORP (ISCO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, International Stem Cell CORP carries a market cap of $1.52M, a P/E ratio of -2.92x, a P/B ratio of -0.36x, a P/S ratio of 0.16x, an enterprise value of $3.69M, and an EV/EBITDA multiple of -13.56x. On profitability, it posts a gross margin of 54.96%, an operating margin of -4.67%, a net margin of -5.47%, a Return on Equity (ROE) of 12.80%, and a Return on Assets (ROA) of -9.81%. Per share, it reports EPS of $-0.06, diluted EPS of $-0.06, free cash flow per share of $0.04, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 3.40% year-over-year, net income growth of 71.62% year-over-year, and EPS growth of 71.62% year-over-year. On the balance sheet, it maintains a current ratio of 0.79x, a quick ratio of 0.41x, working capital of $-1.06M, a debt-to-equity ratio of -1.18x, a debt ratio of 0.99, an interest coverage ratio of -111.00x, free cash flow of $333.00K (TTM), and net debt of $2.17M. Figures sourced from SEC EDGAR.
- Market Cap
- $1.52M
- P/E TTM
- -2.92x
- EPS TTM
- $-0.06
- P/B TTM
- -0.36x
- ROE TTM
- 12.80%
- ROA TTM
- -9.81%
- Debt To Equity
- -1.18x
- Free Cash Flow TTM
- $333.00K
- Net Revenue TTM Growth 1Y
- 3.40%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is International Stem Cell CORP in?
International Stem Cell CORP (ISCO) operates in the Pharmaceutical Preparations industry.
What exchange does ISCO trade on?
International Stem Cell CORP (ISCO) trades on the OTC.
Where is International Stem Cell CORP incorporated?
International Stem Cell CORP is incorporated in DE.
When was International Stem Cell CORP (ISCO)'s most recent SEC filing?
International Stem Cell CORP (ISCO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is ISCO's market cap?
International Stem Cell CORP (ISCO) has a market capitalization of $1.52M as of 2026-06-30.
What is ISCO's EPS (earnings per share)?
International Stem Cell CORP (ISCO)'s trailing twelve month EPS is $-0.06 as of 2026-06-30.
What is ISCO's ROE (return on equity)?
International Stem Cell CORP (ISCO)'s trailing twelve month Return on Equity (ROE) is 12.80% as of 2026-06-30.
What is ISCO's ROA (return on assets)?
International Stem Cell CORP (ISCO)'s trailing twelve month Return on Assets (ROA) is -9.81% as of 2026-06-30.
What is ISCO's EV/EBITDA?
International Stem Cell CORP (ISCO)'s trailing twelve month EV/EBITDA is -13.56x as of 2026-06-30.